2013 || Aarkstore.in || Orphan Drugs in Europe: Pricing, Reimbursement, Funding - PowerPoint PPT Presentation

About This Presentation
Title:

2013 || Aarkstore.in || Orphan Drugs in Europe: Pricing, Reimbursement, Funding

Description:

Aarkstore.in announces Latest report - Orphan Drugs in Europe: Pricing, Reimbursement, Funding – PowerPoint PPT presentation

Number of Views:166
Slides: 10
Provided by: Lavanya86
Category: Other

less

Transcript and Presenter's Notes

Title: 2013 || Aarkstore.in || Orphan Drugs in Europe: Pricing, Reimbursement, Funding


1

Introduction Aarkstore Enterprise
Our comprehensive and wide range of databank in
the field of Market Research Report provides
exclusive, pioneering and innovative service to
our report buyers. Our high-quality databank
comprises of company profiles, strategy review,
company report, industry reports, company
financials, industry research, SWOT analysis, and
so on Aarkstore.com is in the forefront as it
is enriched with comprehensive informative and
interactive search features. One can browse to
have ample access of beyond 2.5 lakh business
industry reports.
2
Category
  • Pharmaceuticals Healthcare Market Research
    Reports http//www.aarkstore.co
    m/market-sector-reports/Pharmaceuticals--Healthca
    re-7.html

3
Report
2013 Orphan Drugs in Europe Pricing,
Reimbursement, Funding Aarkstore.in
http//aarkstore.in/Orphan-Drugs-in-Europe-Prici
ng-Reimbursement-Funding.html
4
Request Sample
http//www.aarkstore.com/Report/SampleRequest.asp?
RptId139609
5
Summary
  • The cost of treating rare disease in an age
    when austerity measures are hitting total
    healthcare funding across Europe is a highly
    controversial, even emotive subject. There is a
    clear and pressing clinical need, a strong
    patient voice and the treatments themselves
    sometimes offer the only hope. But is this enough
    to assure premium prices and special status in an
    era of budget limitations, and growing demands
    for evidence of clinical and cost effectiveness?


  • More

6
Table of Contents
  • Executive Summary   1. EU rphan Drug
    Regulatin 1.1 bjectives 1.2 Qualifying
    Criteria 1.3 Prcedure/Timetable 1.4
    Incentives 1.4.1 Prtcl Assistance 1.4.2
    Marketing Apprval Assistance 1.4.2.1 Pririty
    review/fast track assessment 1.4.2.2 Lwer
    regulatry fees 1.4.3 Marketing
    Exclusivity 1.4.3.1 Issues relating t
    similarity 

    More

7
Latest Reports
http//www.aarkstore.com/publishers/JustPharmaRe
ports-12.htmlRisk Sharing and Other Forms of
Managed Entry Agreements for Medicines,
Worldwide  Pharmaceutical Pricing
Distribution in Japan, 2012 Update  Biosimilars
Current Situation Future Prospects,
Worldwide  Orphan Drugs in Europe Pricing,
Reimbursement, Funding Market Access Issues,
2011 Edition  Market Access Korea Breaking
into the Developed Worlds Fastest Growing
Pharmaceutical Market
8
(No Transcript)
9
Contact us
For More details about above other Reports
please contact Lavanya Aarkstore.com Contact
Marketing team Mob.No.918149852585 Email
Customersupport_at_aarkstore.com URL
http//www.aarkstore.com
http//aarkstore.in/
Write a Comment
User Comments (0)
About PowerShow.com